- Home
- SABS vs ARTW Comparison
SABS vs ARTW Comparison
Compare SABS & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- ARTW
- Stock Information
- Founded
- SABS 2014
- ARTW 1956
- Country
- SABS United States
- ARTW United States
- Employees
- SABS N/A
- ARTW N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- ARTW Industrial Machinery/Components
- Sector
- SABS Health Care
- ARTW Industrials
- Exchange
- SABS Nasdaq
- ARTW Nasdaq
- Market Cap
- SABS 15.8M
- ARTW 17.2M
- IPO Year
- SABS N/A
- ARTW N/A
- Fundamental
- Price
- SABS $2.02
- ARTW $4.24
- Analyst Decision
- SABS Strong Buy
- ARTW
- Analyst Count
- SABS 5
- ARTW 0
- Target Price
- SABS $10.00
- ARTW N/A
- AVG Volume (30 Days)
- SABS 4.3M
- ARTW 68.1K
- Earning Date
- SABS 08-07-2025
- ARTW 10-03-2025
- Dividend Yield
- SABS N/A
- ARTW N/A
- EPS Growth
- SABS N/A
- ARTW N/A
- EPS
- SABS N/A
- ARTW 0.44
- Revenue
- SABS $114,698.00
- ARTW $23,523,353.00
- Revenue This Year
- SABS N/A
- ARTW N/A
- Revenue Next Year
- SABS N/A
- ARTW N/A
- P/E Ratio
- SABS N/A
- ARTW $11.34
- Revenue Growth
- SABS N/A
- ARTW N/A
- 52 Week Low
- SABS $1.00
- ARTW $1.43
- 52 Week High
- SABS $6.60
- ARTW $4.22
- Technical
- Relative Strength Index (RSI)
- SABS 42.28
- ARTW 75.10
- Support Level
- SABS $1.85
- ARTW $3.45
- Resistance Level
- SABS $2.26
- ARTW $4.18
- Average True Range (ATR)
- SABS 0.26
- ARTW 0.33
- MACD
- SABS -0.06
- ARTW 0.08
- Stochastic Oscillator
- SABS 16.71
- ARTW 100.00
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.